AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 33 filers reported holding AADI BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,063 | -29.2% | 26,666 | 0.0% | 17.55% | -29.6% |
| Q2 2023 | $182,395 | -5.5% | 26,666 | 0.0% | 24.91% | +40.3% |
| Q1 2023 | $193,062 | -43.6% | 26,666 | 0.0% | 17.76% | -32.0% |
| Q4 2022 | $342,125 | -9.3% | 26,666 | 0.0% | 26.12% | +2.2% |
| Q3 2022 | $377,000 | +14.6% | 26,666 | 0.0% | 25.56% | +4.4% |
| Q2 2022 | $329,000 | -27.4% | 26,666 | 0.0% | 24.48% | -20.9% |
| Q1 2022 | $453,000 | -29.7% | 26,666 | 0.0% | 30.96% | -16.9% |
| Q4 2021 | $644,000 | -17.8% | 26,666 | 0.0% | 37.25% | +14.5% |
| Q3 2021 | $783,000 | – | 26,666 | – | 32.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $129,063 | 17.55% |
| Alerce Investment Management, L.P. | 1,630,830 | $7,893,217 | 13.49% |
| ACUTA CAPITAL PARTNERS, LLC | 1,849,402 | $8,951,106 | 6.00% |
| Decheng Capital Management III (Cayman), LLC | 526,329 | $2,547,432 | 0.85% |
| Vivo Capital, LLC | 509,572 | $6,456,277 | 0.71% |
| Knott David M Jr | 265,000 | $1,283 | 0.49% |
| Ghost Tree Capital, LLC | 250,000 | $1,210,000 | 0.40% |
| Avoro Capital Advisors LLC | 2,849,402 | $13,791,106 | 0.22% |
| Lion Point Capital, LP | 82,423 | $398,927 | 0.18% |
| Soleus Capital Management, L.P. | 333,227 | $1,612,819 | 0.15% |